abstract |
The invention rhubarb (Rhei The present invention relates to a pharmaceutical composition for the prevention and treatment of diseases caused by ICAM-1 and LFA-1 mediated cell adhesion, comprising Rhizoma ) extract or fractions thereof, or stilbene-based compounds derived from them. More specifically, the present invention provides a pharmaceutical for preventing or treating infectious diseases caused by rhinoviruses, coxsackieviruses, malaria or HIV-1, including Rhei Rhizoma extract or fractions thereof, or stilbene compounds derived therefrom. To a red composition. The present invention also relates to external skin preparations, foodstuffs and personal care products containing the composition. |